Paper39376010
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.
Clarke BL and 19 others. J Clin Endocrinol Metab, 2025. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial. Papers, record 39376010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39376010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypoparathyroidism | Major topic |
| Parathyroid Hormone | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Adult | |
| Double-Blind Method | |
| Calcium | |
| Bone Density | |
| Treatment Outcome | |
| Aged | |
| Quality of Life |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Ascendis Pharma Bone Diseases A/S, Hellerup, Denmark | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 39903658 | Correction to: "Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial". | https://conductscience.org/library/papers/39903658 |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34347093 | PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism. | J Clin Endocrinol Metab | 2022 | https://conductscience.org/library/papers/34347093 | PubMed |
| 2 | 34374868 | Psychometric validation of the Hypoparathyroidism Patient Experience Scales (HPES). | J Patient Rep Outcomes | 2021 | https://conductscience.org/library/papers/34374868 | PubMed |
| 3 | 31721256 | Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey. | Clin Endocrinol (Oxf) | 2020 | https://conductscience.org/library/papers/31721256 | PubMed |
| 4 | 28822059 | Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. | Endocrine | 2017 | https://conductscience.org/library/papers/28822059 | PubMed |
| 5 | 28857066 | Hypoparathyroidism. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/28857066 | PubMed |
| 6 | 36271471 | Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. | J Bone Miner Res | 2023 | https://conductscience.org/library/papers/36271471 | PubMed |
| 7 | 36054621 | Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop. | J Bone Miner Res | 2022 | https://conductscience.org/library/papers/36054621 | PubMed |
| 8 | 26943719 | Management of Hypoparathyroidism: Summary Statement and Guidelines. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/26943719 | PubMed |
| 9 | 31291476 | Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism. | J Bone Miner Res | 2019 | https://conductscience.org/library/papers/31291476 | PubMed |
| 10 | 31552607 | Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom). | Patient | 2020 | https://conductscience.org/library/papers/31552607 | PubMed |
| 11 | 34825891 | Low health-related quality of life in hypoparathyroidism and need for PTH analog. | Endocr Connect | 2022 | https://conductscience.org/library/papers/34825891 | PubMed |
| 12 | 26943721 | Presentation of Hypoparathyroidism: Etiologies and Clinical Features. | J Clin Endocrinol Metab | 2016 | https://conductscience.org/library/papers/26943721 | PubMed |
| 13 | 33200346 | Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism. | Rev Endocr Metab Disord | 2021 | https://conductscience.org/library/papers/33200346 | PubMed |
| 14 | 32765831 | Recent advances in understanding and managing hypoparathyroidism. | F1000Res | 2020 | https://conductscience.org/library/papers/32765831 | PubMed |
| 15 | 32212275 | A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults. | J Bone Miner Res | 2020 | https://conductscience.org/library/papers/32212275 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978850 | Eneboparatide induces prolonged 24-hour PTH 1 receptor activation. | Ther Adv Rare Dis | 2026 | https://conductscience.org/library/papers/42978850 | PubMed |
| 42881908 | Contemporary and Emerging Therapeutic Strategies in Hypoparathyroidism: From Conventional Treatment to Restoration of Parathyroid Function. | J Clin Med | 2026 | https://conductscience.org/library/papers/42881908 | PubMed |
| 42768234 | Immunogenicity Profile of Lonapegsomatropin During Long-Term Treatment in Children With Growth Hormone Deficiency. | AAPS J | 2026 | https://conductscience.org/library/papers/42768234 | PubMed |
| 42733369 | [Resolution of the Joint Meeting of the Expert Council "Hypoparathyroidism in the Era of Complex Problems and Breakthrough Technologies"]. | Probl Endokrinol (Mosk) | 2026 | https://conductscience.org/library/papers/42733369 | PubMed |
| 42614145 | Palopegteriparatide treatment for hypoparathyroidism in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: a case series and literature update. | JBMR Plus | 2026 | https://conductscience.org/library/papers/42614145 | PubMed |
| 42560456 | Italian guidelines for the management of adult individuals with post-surgical hypoparathyroidism. | J Endocrinol Invest | 2026 | https://conductscience.org/library/papers/42560456 | PubMed |
| 42440695 | Pharmacodynamics of sustained levels of PTH following palopegteriparatide treatment in adults with hypoparathyroidism. | J Endocr Soc | 2026 | https://conductscience.org/library/papers/42440695 | PubMed |
| 42435057 | Clinical Characteristics, Treatment Patterns, and Complications in Permanent Hypoparathyroidism: A Large Retrospective Cross-Sectional Study. | Calcif Tissue Int | 2026 | https://conductscience.org/library/papers/42435057 | PubMed |
| 42227095 | [Complications of Pseudohypoparathyroidism and Congenital Forms of Hypoparathyroidism in Children]. | Probl Endokrinol (Mosk) | 2026 | https://conductscience.org/library/papers/42227095 | PubMed |
| 42081067 | Risk factors of renal complications in childhood-onset non-surgical hypoparathyroidism: a long-term follow-up study. | Endocrine | 2026 | https://conductscience.org/library/papers/42081067 | PubMed |
| 41961369 | Management of patients with hypoparathyroidism: a Delphi consensus analysis. | J Endocrinol Invest | 2026 | https://conductscience.org/library/papers/41961369 | PubMed |
| 41909156 | Successful transition from rhPTH(1-84) to palopegteriparatide in chronic hypoparathyroidism. | JCEM Case Rep | 2026 | https://conductscience.org/library/papers/41909156 | PubMed |
| 41805032 | Neural plasticity impairment in chronic post-surgical hypoparathyroidism: a cross-sectional and prospective pilot study. | Endocr Connect | 2026 | https://conductscience.org/library/papers/41805032 | PubMed |
| 41780637 | Discovery and characterization of canvuparatide, a once-weekly parathyroid hormone analog for the treatment of hypoparathyroidism. | Mol Metab | 2026 | https://conductscience.org/library/papers/41780637 | PubMed |
| 41365829 | Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension. | J Clin Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41365829 | PubMed |
| 41335198 | Unveiling the complexities of hypoparathyroidism: a comprehensive review of clinical manifestations, diagnosis, and novel therapies. | J Endocrinol Invest | 2026 | https://conductscience.org/library/papers/41335198 | PubMed |
| 41260697 | Palopegteriparatide in Japanese adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway Japan trial. | Endocr J | 2026 | https://conductscience.org/library/papers/41260697 | PubMed |
| 41134515 | Value Contribution of Palopegteriparatide in Adult Patients with Chronic Hypoparathyroidism using Multicriteria Decision Analysis (MCDA). | Adv Ther | 2025 | https://conductscience.org/library/papers/41134515 | PubMed |
| 40956444 | Rebound Effect Following the Discontinuation of Palopegteriparatide. | Calcif Tissue Int | 2025 | https://conductscience.org/library/papers/40956444 | PubMed |
| 40924119 | The cellular effect of intermittent PTH treatment on bone remodeling and modeling in humans-a histomorphometry centered scoping review. | Osteoporos Int | 2025 | https://conductscience.org/library/papers/40924119 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PTH | 5741 | PubTator's text mining | https://conductscience.org/library/genes/5741 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39376010
GET https://conductscience.org/api/papers/v1/39376010/cited_by?page=2